The PROTEMBO Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 284 participants.
Also called NCT05873816
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 284 participants
- Sponsor
- Protembis GmbH
- Registry
-
NCT05873816
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Germany, Poland
- Registry status
- Completed
Technical summary
Registry record NCT05873816. Randomized; double masking; primary purpose prevention. Start 2024-03-21 (actual); primary completion 2025-10-18 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The PROTEMBO Trial
- Condition
- Severe Aortic Valve Stenosis
- Intervention (Device)
- ProtEmbo - Cerebral Embolic Protection
- Intervention (Device)
- Sentinel - Cerebral Embolic Protection
- Lead sponsor
- Protembis GmbH
Record details
- Record id
cardio:ct-nct05873816- Content hash
9d8c892f3208f92565b915a1467832dfedcc72e25d2c2eb21867166bfe49cac7